Accredited Investors Employee Shareholders Institutions Private Companies Who We Serve Trading and InvestingData SolutionsPrivate Asset Custody Institutional TradingForge ProTrade private companies with Forge’s institutional brokerage toolBrowse CompaniesIndividual InvestingForge MarketsFind new private company investment opportunitiesForge DataAnalyze private markets via Forge’s intuitive web applicationForge Private Market IndexMonitor a benchmark for actively traded private companies Forge Accuidity Private Market IndexInvest in an institutionally-managed diversified basket of private companies (QPs only)Self-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRASolutions All InsightsPrivate Market ReportsMarket InsightsBuying and Selling Pre-IPO All ReportsPrivate Market Updates Forge Investment OutlookStartup News and TrendsPrivate Market Data and AnalyticsTech IPO Calendar for 2024Private Market ExplainedBuying Pre-IPO SharesSelling Pre-IPO Shares Glossary Videos FAQsInsights About Us Leadership Investor Relations People & Culture Careers About

Impel NeuroPharma Stock

Q: How to sell Impel NeuroPharma stock?

If you hold private company shares of Impel NeuroPharma - whether as an employee or an early investor - Forge can help you sell them. 1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have. 2. Indicate your interest to sell your Impel NeuroPharma stock on our platform. 3. Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.

impelnp.comHealthcare / BioTech & PharmaFounded: 2008Funding to Date: $122.85MM

Impel NeuroPharma is a biotechnology company devoted to creating life-changing, innovative therapies for central nervous system (CNS) diseases.

Buy or sell Impel NeuroPharma stockLearn more about Impel NeuroPharma IPO

OverviewFinancingsValuation

Enterprise Value

Access Impel NeuroPharma’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Impel NeuroPharma.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Jon Congleton

Chief Executive Officer, President & Board Member

Meghan Swardstrom

Vice President, Clinical Operations

Ellen Lubman

Chief Business Officer

Scott Youmans

Senior Vice President, Engineering

Mike Malafronte

Vice President of Quality Assurance

John Hoekman Ph.D

Co-Founder, Chief Scientific Officer & Board Member

Lynn Gold Ph.D

Senior Vice President, Regulatory

Stephen Shrewsbury

Chief Medical Officer

Board Members

Ali Satvat

Kohlberg Kravis Roberts

H. Stewart Parker

Mahendra Shah Ph.D

Vivo Capital

David Allison Ph.D

5AM Ventures

Diane Wilfong

John Hoekman Ph.D

Robert Mittendorff MD

Norwest Venture Partners

Aaron Royston MD

venBio

James Young Ph.D

5AM Ventures

Jon Congleton

Timothy Nelson

Impel NeuroPharma stock FAQs

Can you buy Impel NeuroPharma stock?

As Impel NeuroPharma is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company like Impel NeuroPharma, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.

How to buy Impel NeuroPharma stock?

To invest in a private company like Impel NeuroPharma through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

Create a free account to access Forge’s marketplace.
Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.

Can you sell Impel NeuroPharma stock?

Yes, you may be able to sell your Impel NeuroPharma stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company's interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.

How to sell Impel NeuroPharma stock?

If you hold private company shares of - whether as an employee or an early investor - Forge can help you sell them.

Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
Indicate your interest to sell your Impel NeuroPharma stock on our platform.
Work with your dedicated Private Market Specialist who'll help guide you through every step of the transaction.

Is Impel NeuroPharma a public company?

No, Impel NeuroPharma is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

What is Impel NeuroPharma’s stock price?

Impel NeuroPharma is a privately held company and therefore does not have a public stock price. However, you may access Impel NeuroPharma’s private market stock price with Forge Data.

What is Impel NeuroPharma’s stock ticker symbol?

Impel NeuroPharma does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Market Screener 10/17/2019

Impel NeuroPharma : Announces Appointment Of Diane Wilfong To Board Of Directors

FinSMEs 12/07/2018

Impel NeuroPharma Closes $67.5M in Series D Financing | FinSMEs

Impel NeuroPharma, a biotech company focused on developing therapies for the treatment of CNS disorders, completed a $67.5m Series D financing

Browse More Insights

Frequently Asked Questions

Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.